Back to results
US 2019/0160105 A1Published application
Methods for selecting improved stem cell for treating intraventricular hemorrhage of premature infants
AssigneeSamsung Life Public Welfare Foundation
InventorsYun Sil CHANG, Won Soon PARK, So Yoon AHN, Dong Kyung SUNG
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a method for selecting a high efficacy stem cell for treating intraventricular hemorrhage in premature infants, and more particularly, to a method for selecting a high efficacy stem cell for treating intraventricular hemorrhage, including a step of measuring an expression level of a vascular endothelial growth factor (VEGF) and a high efficacy stem cell selected by the method.
Claims18
A method for selecting a high efficacy stem cell for treating a cerebrovascular disease, the method comprising:
- measuring an expression level of a vascular endothelial growth factor (VEGF).
Dependencies are inferred from the claim text.